As somatic PRUNE2 mutations are considered significant in the pathogenesis of PC, we wanted to study whether germline PRUNE2 mutations might be identified in patients diagnosed with aggressive parathyroid tumors in the genetically homogenous Finnish population, an ideal population for the discovery of rare genetic defects of monogenic diseases [32]. The gene discussed is PRUNE2; the disease is tumor of parathyroid gland.